, service expenses and the remuneration of the executives of the Company (excluding financial cost and fuel cost) (meaning total expenses from the standalone financial statements net loss on sales of
Expenses 31.25 35.24 (3.99) (11.13) Net Profit (Loss) (59.03) 58.74 (117.77) (200.49) Earnings per share (Baht per share) (0.05) 0.05 (0.10) (200.00) Net Profit The company and subsidiaries realized net loss
GFPT Public Company Limited Interim Management Discussion and Analysis for the 1st Quarter 2018 Page 1 of 11 Management Discussion and Analysis This interim MD&A report has been prepared based on the
income tax (income) expenses (380) Profit (loss) for the period before adjusting to new standard (39,024) 4 Zen Corporation Group Public Company Limited 662 Soi Onnuch 17, Suanluang, Bangkok 10250 THAILAND
the Company only, the profit for the period was Baht 20 million, decreased from the prior year same period at Baht 7 million or decreased 24.2 percent while subsidiary’s loss for the period at Baht 8
์ - 34-0135 www.interpharma.co.th Inter Pharma Public Company Limited 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawongse, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135
Public Co., Ltd. would like to submit the financial statement of the Company and subsidiary companies for the year 2017 and present the details of the performance of the Company as follows: 2017 was the
) 90.67 (173.20) (191.02) Earnings per share (Baht per share) (0.02) 0.02 (0.04) (200.00) Net Profit The company and subsidiaries realized net loss as of the fiscal year 2015, ended as of December 31, 2015
) 90.67 (173.20) (191.02) Earnings per share (Baht per share) (0.02) 0.02 (0.04) (200.00) Net Profit The company and subsidiaries realized net loss as of the fiscal year 2015, ended as of December 31, 2015
WATTANAPAT HOSPITAL TRANG PUBLIC COMPANY LIMITED No. WPH – SET 7/2019 10 May 2019 Subject : Management Discussion and Analysis for Quarter 1 of 2019 ending on 31 March 2019. To : Directors and